Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
基本信息
- 批准号:10153904
- 负责人:
- 金额:$ 72.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAfrican Green MonkeyAgeAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease riskAnimalsApplied ResearchAreaAutopsyBehavioralBiologicalBiological MarkersBiomedical ResearchBiopsyBlood Chemical AnalysisCardiometabolic DiseaseCaribbean regionCategoriesCercopithecus tantalusCerebrospinal FluidClinical and Translational Science AwardsCommunicable DiseasesCommunitiesConsultationsDataDengue FeverDevelopmentDiabetes MellitusDisciplineEnsureEtiologyEvaluationFatty acid glycerol estersFosteringFundingGeneticGenomeGenotypeHealthInfluenzaInfrastructureInvestigationLipidsLongevityMaintenanceMeasurementMedicineMetabolicMetabolic DiseasesMethodologyMothersMultimodal ImagingMuscleNeonatalNeurodegenerative DisordersNeurosciencesObesityPhenotypePhysiologicalPlasmaPlayPopulationPrimatesResearchResearch PersonnelResourcesRespiratory syncytial virusRoleSamplingServicesSiteSourceStudy modelsSynapsesTechnical ExpertiseTissuesTrainingTranslational ResearchUnited States National Institutes of HealthVaccinesVeterinariansVeterinary PathologyViralanimal resourcebioimagingbiomedical resourcecardiometabolismcareerclinical careclinical phenotypecomparativedata archivedata repositoryforestgene therapygenetic pedigreegenetic resourcehuman diseasehuman modelimaging capabilitiesimaging programinterestmedical schoolsmeetingsnonhuman primatenoveloutreachpathogenphenotypic dataprecision medicineprogramspsychosocial developmentrepositoryreproductiveresearch facilityscreeningsocial grouptraining opportunitytranslational modeltranslational studyvaccine developmentvervetβ-amyloid burden
项目摘要
This application is a competing renewal of the "Vervet Research Colony as a Biomedical Resource"
(VRC, P40-OD010965). The VRC is the only NIH-funded biomedical research resource for US-born
vervet/African green monkeys (AGM; Chlorocebus aethiops sabaeus) and has been continuously funded
since 2005. The VRC serves a wide range of local, regional and national investigators by providing
animals, biological samples, data, consultation and training pertaining to the use of vervets/AGMs
as multi-categorical, translational models of human disease. Since the previous renewal, the VRC
has provided resources to over 100 investigators, including over 250 animals and over 1,500
biological samples, as well as data and consultation. The VRC has also provided the necessary
infrastructure and technical expertise enabling the on-site use of over 600 animals across 30
different studies. The VRC has facilitated critical translational research across a wide variety of
disciplines, including: a) the development of the vervet as an emerging nonhuman primate model of
Alzheimer's disease risk with a focus on the assessment of amyloid burden, neurodegenerative
disease biomarkers, and synaptic degeneration; b) investigations into the efficacy and enhancement
of vaccines for infectious diseases such as neonatal influenza, respiratory syncytial virus, and
dengue fever; c) studies focused on the etiology and health consequences of diabetes, metabolic
disease and obesity; d) the development of novel, non-invasive biomedical imaging methodologies;
and e) the expansion of the critical genetic resources available for vervets, including the
sequencing of the vervet genome. The aims of the VRC resource are to: 1) provide the scientific
community with access to animals, biological samples, data and expertise to facilitate the use of
vervets for a wide-range of biomedical research; 2) to provide exceptional training opportunities
for veterinarians and researchers interested in using vervets for translational research, and to
serve as a platform for community and scientific outreach to foster better understanding of the use
of nonhuman primates in biomedical research; and 3) to enhance the resource by engaging in applied
research focused on continuing genetic and phenotypic characterization of vervets across the
lifespan and evaluation of the vervet as a potential translational model in novel research areas.
The VRC is a critical component of the Wake Forest Clinical and Translational Science Award (CTSA),
which provides administrative support and facilitates the utilization of the VRC resource across
the larger CTSA network. The VRC is able to take full advantage of a wide-range of existing
research facilities within the Wake Forest School of Medicine, including multi-modal imaging
capabilities, veterinary and pathology expertise, and genetic and analytic resources.
该应用程序是“黑长尾猴研究群体作为生物医学资源”的竞争性更新
(VRC,P40-OD010965)。 VRC 是美国国立卫生研究院 (NIH) 资助的唯一针对美国出生的生物医学研究资源
黑长尾黑颚猴/非洲绿猴(AGM;Chlorocebus aethiops sabaeus)并持续获得资助
自 2005 年以来。VRC 为广泛的地方、区域和国家调查人员提供服务
与黑长尾黑颚猴/AGM 使用相关的动物、生物样本、数据、咨询和培训
作为人类疾病的多类别转化模型。自上次更新以来,VRC
已为 100 多名研究人员提供资源,其中包括 250 多只动物和 1,500 多只动物
生物样本以及数据和咨询。 VRC 还提供了必要的
基础设施和技术专业知识使 30 个国家/地区的 600 多只动物能够在现场使用
不同的研究。 VRC 促进了各种重要的转化研究
学科,包括:a)黑长尾黑颚猴作为新兴非人类灵长类动物模型的发展
阿尔茨海默病风险,重点评估淀粉样蛋白负荷、神经退行性疾病
疾病生物标志物和突触变性; b) 功效和增强的调查
新生儿流感、呼吸道合胞病毒等传染病疫苗
登革热; c) 研究重点是糖尿病的病因学和健康后果、代谢
疾病和肥胖; d) 开发新颖的、非侵入性的生物医学成像方法;
e) 扩大可用于长尾黑颚猴的关键遗传资源,包括
长尾黑颚猴基因组测序。 VRC 资源的目标是: 1) 提供科学的
能够获得动物、生物样本、数据和专业知识的社区,以促进使用
用于广泛的生物医学研究的长尾黑颚猴; 2)提供特殊的培训机会
对于有兴趣使用黑长尾猴进行转化研究的兽医和研究人员,以及
作为社区和科学推广的平台,以促进更好地了解其用途
非人类灵长类动物在生物医学研究中的应用; 3)通过从事应用来增强资源
研究重点是长尾黑颚猴的持续遗传和表型特征
长尾黑颚猴的寿命和评估作为新研究领域的潜在转化模型。
VRC 是维克森林临床和转化科学奖 (CTSA) 的重要组成部分,
它提供管理支持并促进 VRC 资源的利用
更大的 CTSA 网络。 VRC 能够充分利用各种现有的
维克森林医学院内的研究设施,包括多模态成像
能力、兽医和病理学专业知识以及遗传和分析资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Jorgensen其他文献
Matthew Jorgensen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew Jorgensen', 18)}}的其他基金
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10285192 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群
- 批准号:
10379068 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10612842 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
9471459 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
Vervet Research Colony as a Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10119382 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10806701 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
The Vervet Research Colony as Biomedical Resource
作为生物医学资源的黑长尾黑长尾猴研究群体
- 批准号:
10710813 - 财政年份:2004
- 资助金额:
$ 72.38万 - 项目类别:
相似国自然基金
非洲绿猴血管内皮细胞microRNA表达谱分析及功能研究
- 批准号:31501908
- 批准年份:2015
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
非洲绿猴细胞限制因子Trim5αSPRY区插入子在抗HIV-1感染中的作用
- 批准号:30571661
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
Linking evolution to aging through DNA methylation and CpG density by examining twelve mammalian species
通过检查 12 种哺乳动物,通过 DNA 甲基化和 CpG 密度将进化与衰老联系起来
- 批准号:
10371683 - 财政年份:2022
- 资助金额:
$ 72.38万 - 项目类别:
Linking evolution to aging through DNA methylation and CpG density by examining twelve mammalian species
通过检查 12 种哺乳动物,通过 DNA 甲基化和 CpG 密度将进化与衰老联系起来
- 批准号:
10597245 - 财政年份:2022
- 资助金额:
$ 72.38万 - 项目类别:
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's Disease
阿尔茨海默病中年龄与认知相关的细胞衰老的解耦
- 批准号:
10454751 - 财政年份:2020
- 资助金额:
$ 72.38万 - 项目类别:
Uncoupling Age- Versus Cognitive-Related Cellular Senescence in Alzheimer's Disease
阿尔茨海默病中年龄与认知相关的细胞衰老的解耦
- 批准号:
10043941 - 财政年份:2020
- 资助金额:
$ 72.38万 - 项目类别:
Novel hybrid molecule with both IOP lowering and neuroprotective effects for treatment of glaucoma
具有降低眼压和神经保护作用的新型混合分子可用于治疗青光眼
- 批准号:
10477236 - 财政年份:2020
- 资助金额:
$ 72.38万 - 项目类别: